News
Caring Cross, Wellbeing Foundation Africa Partner to Improve Access to Advanced Therapies in Nigeria
The nonprofit says its pipeline offers more affordable and accessible therapeutics, including point-of-care CAR-T cell therapy for leukemia and lymphoma.
The firm enrolled the first patient at Florida's BayCare Morton Plant Hospital, and the study procedure went according to protocol, per an investigator.
The firm is expecting Phase III readouts this year for its FGFR2b drug bemarituzumab and is advancing a second KRAS inhibitor to the clinic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback